PACTR201803003160262招募中未知
Comparative Effectiveness of six-week treatment course of vitamin D2 and D3 in children with sickle cell anaemia in steady state: A randomized clinical Trial
未提供0 个研究点目标入组 154 人开始时间: 2018年3月3日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 154
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 1 Year(s) 至 18 Year(s)（—）
- 性别
- All
入选标准
- •Children with sickle cell anaemia aged 1 to 18 years
- •Children with 25(OH)D level below 75nmol/L
- •Children whose parents give consent
- •Children 7 years and above that assent to be part of the study
排除标准
- •Children with established diagnosis of tuberculosis, asthma or on steroid
- •Children with established renal or kidney disease
- •Children on anticonvulsants
研究者
相似试验
进行中（未招募）
1 期
Therapeutic efficacy comparison of a six-month treatment by itraconazole and nebulised Ambisome® versus treatment by itraconazole alone in non- or mildly- immunocompromised patients with Chronic Pulmonary Aspergillosis: a prospective, randomized, single blind study, (single aspergilloma excluded).MedDRA version: 20.1 Level: LLT Classification code 10022881 Term: Invasive bronchopulmonary aspergillosis System Organ Class: 100000004862EUCTR2018-000972-14-FRCHU DE POITIERS224
进行中（未招募）
不适用
Evaluation of the effect of 6 months treatment with V0191 on symptoms changes in patients with Mild Cognitive Impairment. Multicentre, randomised, double-blind, placebo-controlled study in parallel groups.EUCTR2007-001975-12-BEPIERRE FABRE MEDICAMENT - IDPF200
进行中（未招募）
不适用
Evaluation of the effect of 6 months treatment with V0191 on symptoms changes in patients with Mild Cognitive Impairment. Multicentre, randomised, double-blind, placebo-controlled study in parallel groups.Mild Cognitive ImpairmentMedDRA version: 9.1Level: LLTClassification code 10009846Term: Cognitive impairmentEUCTR2007-001975-12-FIPIERRE FABRE MEDICAMENT - IDPF210
进行中（未招募）
1 期
Evaluation of the effect of 6 months treatment with V0191 on symptoms changes in patients with Mild Cognitive Impairment. Multicentre, randomised, double-blind, placebo-controlled study in parallel groups.Mild Cognitive ImpairmentMedDRA version: 9.1Level: LLTClassification code 10009846Term: Cognitive impairmentEUCTR2007-001975-12-FRPIERRE FABRE MEDICAMENT - IDPF200
进行中（未招募）
1 期
Evaluation of the effect of 6 months treatment with DC158AM on fatigue in patients with Parkinson’s disease. Multicentre, randomised, double-blind, placebo-controlled study in parallel groups.Fatigue symptoms in Parkinson's disease.MedDRA version: 9.1 Level: LLT Classification code 10013113 Term: Disease Parkinson'sEUCTR2007-002195-34-FRPIERRE FABRE MEDICAMENT120